Expression of glutamine synthetase in balloon cells: A basis of their antiepileptic role?

Clinical Neuropathology

Volumn 34, Issue 2, 2015, Pages 83-88

  Buccoliero, Anna Maria ^a   Barba, Carmen ^a   Giordano, Flavio ^a   Baroni, Gianna ^b   Genitori, Lorenzo ^a   Guerrini, Renzo ^a   Taddei, Gian Luigi ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Balloon cells; Epilepsy; Focal cortical dysplasia; Glutamine synthetase

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE;

ARTICLE; BRAIN TISSUE; CHILD; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MALFORMATION OF CORTICAL DEVELOPMENT GROUP II; MALFORMATION OF CORTICAL DEVELOPMENT GROUP IIB; NEUROFILAMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; STEREOELECTROENCEPHALOGRAPHY; TREATMENT OUTCOME; WHITE MATTER; BIOSYNTHESIS; COMPLICATION; ENZYMOLOGY; EPILEPSY; MALFORMATION OF CORTICAL DEVELOPMENT GROUP I; PATHOLOGY;

CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GLUTAMATE-AMMONIA LIGASE; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I;

EID: 84925430874     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300794     Document Type: Article

References (20)

1. Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008; 7: 525-537. CrossRef PubMed
2. Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avanzini G, Barkovich AJ, Battaglia G, Becker A, Cepeda C, Cendes F, Colombo N, Crino P, Cross JH, Delalande O, Dubeau F, Duncan J, Guerrini R, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011; 52: 158-174. CrossRef PubMed
3. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry. 1971; 34: 369-387. CrossRef PubMed
4. Han CW, Min BW, Kim Y, Jeong EK, Park CS, Woo YJ, Kim HS, Lee MC. Immunohistochemical analysis of developmental neural antigen expression in the balloon cells of focal cortical dysplasia. J Clin Neurosci. 2011; 18: 114-118. PubMed
5. Oh HS, Lee MC, Kim HS, Lee JS, Lee JH, Kim MK, Woo YJ, Kim JH, Kim HI, Kim SU. Pathophysiologic characteristics of balloon cells in cortical dysplasia. Childs Nerv Syst. 2008; 24: 175-183. CrossRef PubMed
6. Lamparello P, Baybis M, Pollard J, Hol EM, Eisenstat DD, Aronica E, Crino PB. Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain. 2007; 130: 2267-2276. CrossRef PubMed
7. Cepeda C, André VM, Vinters HV, Levine MS, Mathern GW. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia. 2005; 46 (Suppl 5): 82-88. CrossRef PubMed
8. Cepeda C, André VM, Flores-Hernández J, Nguyen OK, Wu N, Klapstein GJ, Nguyen S, Koh S, Vinters HV, Levine MS, Mathern GW. Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits. Dev Neurosci. 2005; 27: 59-76. CrossRef PubMed
9. Boonyapisit K, Najm I, Klem G, Ying Z, Burrier C, LaPresto E, Nair D, Bingaman W, Prayson R, Lüders H. Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic-histopathologic correlations. Epilepsia. 2003; 44: 69-76. CrossRef PubMed
10. Eid T, Behar K, Dhaher R, Bumanglag AV, Lee TS. Roles of glutamine synthetase inhibition in epilepsy. Neurochem Res. 2012; 37: 2339-2350. CrossRef PubMed
11. Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int. 2007; 51: 333-355. CrossRef PubMed
12. Gonsette RE. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci. 2008; 274: 48-53. CrossRef PubMed
13. Eid T, Tu N, Lee TS, Lai JC. Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem Int. 2013; 63: 670-681. CrossRef PubMed
14. DiNuzzo M. Mangia S, Maraviglia B, Giove F. Physiological bases of the K+ and the glutamate/GABA hypothese of epilepsy. Epilepsy Res. 2014; 108: 995-1012. CrossRef PubMed
15. González-Martínez JA, Ying Z, Prayson R, Bingaman W, Najm I. Glutamate clearance mechanisms in resected cortical dysplasia. J Neurosurg. 2011; 114: 1195-1202. CrossRef PubMed
16. Urbach H, Scheffler B, Heinrichsmeier T, von Oertzen J, Kral T, Wellmer J, Schramm J, Wiestler OD, Blümcke I. Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia. 2002; 43: 33-40. CrossRef PubMed
17. Garganis K. Kokkinos V, Zountsas B. Limited resection of focal dysplasia and associated epileptogenic cortex may lead to positive surgical outcome. Epileptic Disord. 2001; 13: 422-429. PubMed
18. Wagner J, Urbach H, Niehusmann P, von Lehe M, Elger CE, Wellmer J. Focal cortical dysplasia type IIb: completeness of cortical, not subcortical, resection is necessary for seizure freedom. Epilepsia. 2011; 52: 1418-1424. CrossRef PubMed
19. Palmini A. Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Lüders HO, Prayson R, Spreafico R, Vinters HV. Terminology and classification of the cortical dysplasias. Neurology. 2004; 62 (6 Suppl 3): S2-S8.PubMed
20. Sisodiya SM, Fauser S, Cross JH, Thom M. Focal cortical dysplasia type II: biological features and clinical perspective. Lancet Neurol. 2009; 8: 830-843. CrossRef PubMed